Position in NVO
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$13,118,301
+$4,251,335 QoQ
Shares Held
273,640
+13.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#133
of 1,348 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OLD NATIONAL BANCORP /IN/ holds $848,734,090 across 14 Drug Manufacturers - General names. NVO ranks #5 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
605,458 | $726,204,549 | |
| 2 | ABBV |
AbbVie Inc.
|
126,179 | $31,751,683 | |
| 3 | JNJ |
Johnson & Johnson
|
99,264 | $25,210,077 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,489 | $18,695,336 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
273,640 | $13,118,301 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
218,238 | $12,574,872 | |
| 7 | PFE |
Pfizer Inc
|
492,066 | $11,848,949 | |
| 8 | AMGN |
Amgen Inc
|
11,639 | $4,214,714 |
All Filings in NVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,118,301 | 273,640 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $8,866,966 | 241,278 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,583,940 | 50,785 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $674,424 | 12,154 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $476,444 | 6,903 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $261,302 | 3,763 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $343,993 | 3,999 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $523,788 | 4,399 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $481,319 | 3,372 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $468,403 | 3,648 | Shares | Sole | 2024-04-15 | |
| No filing history on record for this holder in this stock. | ||||||